Peripheral arterial disease (PAD) - A challenging manifestation of atherosclerosis.
J Nordanstig, C A Behrendt, A W Bradbury...
https://pubmed.ncbi.nlm.nih.gov/37031910/Actively Recruiting
Led by University of Trás-os-Montes and Alto Douro · Updated on 2026-10-30
40
Participants Needed
3
Research Sites
N/A
Total Duration
Peripheral arterial disease PAD mainly affects the lower limbs and reduces blood flow, causing symptoms like intermittent claudication, which involves pain and discomfort during exertion. This study evaluates a personalized multicomponent exercise program combining cardiovascular and resistance training to improve functional capacity in patients with PAD. Researchers aim to use artificial intelligence to analyze individual responses and tailor exercise doses accordingly. Participants will be randomly assigned to either a supervised exercise group or a usual care group. The exercise group will train three times a week for 12 weeks, with sessions lasting 60 to 80 minutes, including aerobic and resistance exercises personalized by pain response and muscle oxygen levels. The usual care group will receive lifestyle advice without a specific exercise program. The study uses wearable technology like near-infrared spectroscopy and accelerometry to monitor muscle oxygen saturation and movements in real time. Throughout the 12-week study, participants will undergo evaluations at the start and end, including measures of walking distances, muscle oxygenation, and muscle strength. Researchers will also assess blood pressure, quality of life, daily walking ability, glucose levels, and physical activity. The study tracks detailed physiological responses to exercise to understand and personalize treatment better. Participation involves regular supervised training sessions or lifestyle monitoring, with assessments to measure treatment effects and safety.
CONDITIONS
Personalised Multicomponent Exercise Programme in Peripheral Arterial Disease
C
Catarina Abrantes, Ph.D.
D
Daniel Santarém, M.Sc.
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
University of Trás-os-Montes and Alto Douro
Lead Sponsor
Research Center in Sports Sciences, Health Sciences and Human Development
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - 12 weeks
Participants in the exercise group will attend supervised cardiovascular and resistance training sessions three times a week for 12 weeks. The control group will follow lifestyle advice without specific exercise instructions.
Three sessions per week
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
J Nordanstig, C A Behrendt, A W Bradbury...
https://pubmed.ncbi.nlm.nih.gov/37031910/Tomas Baltrūnas, Valerija Mosenko, Artūras Mackevičius...
https://pubmed.ncbi.nlm.nih.gov/34112030/Victor Aboyans, Jean-Baptiste Ricco, Marie-Louise E L Bartelink...
https://pubmed.ncbi.nlm.nih.gov/28886620/Stephane Perrey, Marco Ferrari
https://pubmed.ncbi.nlm.nih.gov/29177977/Nils Cornelis, Panagiotis Chatzinikolaou, Roselien Buys...
https://pubmed.ncbi.nlm.nih.gov/33810977/University of Trás-os-Montes and Alto Douro
Lead Sponsor
Research Center in Sports Sciences, Health Sciences and Human Development
Collaborating Sponsor